Literature DB >> 1383155

Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.

D G Storey1, E E Ujack, H R Rabin.   

Abstract

The in vivo regulation of Pseudomonas aeruginosa virulence factors during the chronic lung infections associated with cystic fibrosis is poorly understood. We have developed an approach for the analysis of transcript accumulation of individual virulence factors from the P. aeruginosa populations found in the sputa of patients with cystic fibrosis. This method has been named population transcript accumulation, since we examine the transcript accumulation patterns in RNA extracted from the total bacterial population found in the sputum samples. DNA probes specific for P. aeruginosa elastase (lasB) and exotoxin A (toxA) were used to examine the population transcript accumulation of 21 sputum samples taken from 10 patients. We detected three patterns of population transcript accumulation: lasB and toxA, lasB alone, and neither lasB nor toxA. We also measured the relative levels of elastase and exotoxin A transcript accumulation in 19 of these samples. In the six samples containing both toxA and lasB transcripts, we found that the levels of lasB transcripts were consistently higher than those of toxA. Differences in the stability of the two mRNA species could not completely account for the higher level of lasB population transcript accumulation, since we showed that the mRNA half-life of lasB (11 min) was similar to that of toxA (10 min). Finally, we showed that elastase transcripts could be detected in some samples which contained only mucoid isolates. This finding suggests that both mucoid and nonmucoid populations may be transcribing lasB in the lungs of patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383155      PMCID: PMC258219          DOI: 10.1128/iai.60.11.4687-4694.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  40 in total

Review 1.  Pathogenesis of the pseudomonas lung lesion in cystic fibrosis.

Authors:  R B Fick
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

2.  Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infections.

Authors:  D E Woods; M To; P A Sokol
Journal:  Antibiot Chemother (1971)       Date:  1989

3.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

Review 4.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

5.  Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

Authors:  N Holby; S Olling
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-04

6.  Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement.

Authors:  D E Woods; P A Sokol; L E Bryan; D G Storey; S J Mattingly; H J Vogel; H Ceri
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization.

Authors:  D E Ohman; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Differential regulation by iron of regA and toxA transcript accumulation in Pseudomonas aeruginosa.

Authors:  D W Frank; D G Storey; M S Hindahl; B H Iglewski
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.476

10.  Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.

Authors:  D E Woods; M S Schaffer; H R Rabin; G D Campbell; P A Sokol
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 11.677

View more
  13 in total

1.  Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and LightCycler RT-PCR.

Authors:  C Goerke; M G Bayer; C Wolz
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis.

Authors:  David L Erickson; Ryan Endersby; Amanda Kirkham; Kent Stuber; Dolina D Vollman; Harvey R Rabin; Ian Mitchell; Douglas G Storey
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  A second operator is involved in Pseudomonas aeruginosa elastase (lasB) activation.

Authors:  R M Anderson; C A Zimprich; L Rust
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

4.  In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.

Authors:  Mike S Son; Wallace J Matthews; Yun Kang; David T Nguyen; Tung T Hoang
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

5.  Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa.

Authors:  C Wolz; K Hohloch; A Ocaktan; K Poole; R W Evans; N Rochel; A M Albrecht-Gary; M A Abdallah; G Döring
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

6.  Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.

Authors:  D G Storey; E E Ujack; I Mitchell; H R Rabin
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.609

7.  Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis.

Authors:  D G Storey; E E Ujack; H R Rabin; I Mitchell
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.609

8.  Blocking phosphatidylcholine utilization in Pseudomonas aeruginosa, via mutagenesis of fatty acid, glycerol and choline degradation pathways, confirms the importance of this nutrient source in vivo.

Authors:  Zhenxin Sun; Yun Kang; Michael H Norris; Ryan M Troyer; Mike S Son; Herbert P Schweizer; Steven W Dow; Tung T Hoang
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

9.  Association between transcript levels of the Pseudomonas aeruginosa regA, regB, and toxA genes in sputa of cystic fibrosis patients.

Authors:  T L Raivio; E E Ujack; H R Rabin; D G Storey
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.609

10.  Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.

Authors:  Shantelle L LaFayette; Daniel Houle; Trevor Beaudoin; Gabriella Wojewodka; Danuta Radzioch; Lucas R Hoffman; Jane L Burns; Ajai A Dandekar; Nicole E Smalley; Josephine R Chandler; James E Zlosnik; David P Speert; Joanie Bernier; Elias Matouk; Emmanuelle Brochiero; Simon Rousseau; Dao Nguyen
Journal:  Sci Adv       Date:  2015-07-31       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.